Description

Piramal Enterprises Limited operates as a diversified conglomerate with a global presence across its financial services and pharmaceutical divisions, extending its reach to India, North America, Europe, and Japan. Its core operations are structured into Pharmaceutical Manufacturing & Services and Financial Services segments. The company's financial services arm provides a broad spectrum of funding solutions. This includes offering housing finance to individuals and various financing avenues for the real estate sector, such as private equity, structured credit, senior secured debt, construction funding, and flexible lease rental discounting. Beyond real estate, Piramal extends capital support to vital sectors including infrastructure, renewable energy, road development, industrials, and auto components. Furthermore, it operates a dedicated platform for distressed asset investments, supplying both equity and debt capital. In its pharmaceutical segment, Piramal delivers comprehensive contract development and manufacturing organization (CDMO) services. These encompass drug discovery, the production of active pharmaceutical ingredients (APIs), and formulation manufacturing. Its product range features specialized medications like inhalation and injectable anesthetics, injectable pain management drugs, antibiotics, and intrathecal spasticity management treatments. Additionally, the company markets a variety of popular over-the-counter (OTC) products. These span categories such as pain relief, skincare, children's wellness, digestive aids, women's health, disinfectants, products like Covifind, hygiene and protection items, and essential vitamins, minerals, and supplements. Key OTC brands include Saridon, Lacto Calamine, Little's, I-Pill, Supradyn, Polycrol, Triactiv, Ourdaily, Pulse Oximeters, and Tetmosol. Founded in 1947 and based in Mumbai, India, the company was initially known as Piramal Healthcare Limited before it officially adopted its current name, Piramal Enterprises Limited, in July 2012.